![](/images/graphics-bg.png)
The Effects of Xuefu Zhuyu and Shengmai on the Evolution of Syndromes and Inflammatory Markers in Patients with Unstable Angina Pectoris after Percutaneous Coronary Intervention : A Randomised Controlled Clinical Trial
Joint Authors
Chu, Fuyong
Yang, Xiaochen
He, Qingyong
Chen, Jianxin
Gao, Yonghong
Ai-Ming, Wu
Xing, Yanhui
Wang, Jie
Yan-Wei, Xing
Yao, Kuiwu
Teng, Fei
Source
Evidence-Based Complementary and Alternative Medicine
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-05-08
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
We evaluated the effects of the Xuefu Zhuyu capsule (XFZY) and the Shengmai capsule (SM) on the evolution of syndromes and inflammatory markers in patients with unstable angina pectoris (UAP) after percutaneous coronary intervention (PCI).
Ninety patients with UAP after PCI were randomly and equally assigned to three groups: the XFZY group, the SM group, and the placebo group, with 30 patients in each group.
Six syndrome factors (including Qi deficiency, yin deficiency, yang deficiency, blood stasis, phlegm, and Qi stagnation) and 4 inflammatory markers (high-sensitivity C-reactive protein (Hs-CRP), endothelins-1 (ET-1), matrix metalloproteinases-9 (MMP-9), and homocysteine (Hcy)) were observed at week 0 and at the 1st, 4th and 12th weeks.
In conclusion, the evolution of syndromes present in patients with UAP after PCI followed these trends (1) The deficiency syndromes gradually increased during a 12-week period, but the excess syndromes first gradually decreased and then mildly increased after PCI.
(2) XFZY and SM can prevent excess syndromes from increasing in the later stages and prevent deficiency syndromes from increasing in all stages.
(3) XFZY and SMcan reduce the levels of the inflammatory markers, especially in the later stages after PCI.
American Psychological Association (APA)
Wang, Jie& Yang, Xiaochen& Chu, Fuyong& Chen, Jianxin& He, Qingyong& Yao, Kuiwu…[et al.]. 2013. The Effects of Xuefu Zhuyu and Shengmai on the Evolution of Syndromes and Inflammatory Markers in Patients with Unstable Angina Pectoris after Percutaneous Coronary Intervention : A Randomised Controlled Clinical Trial. Evidence-Based Complementary and Alternative Medicine،Vol. 2013, no. 2013, pp.1-9.
https://search.emarefa.net/detail/BIM-506284
Modern Language Association (MLA)
Wang, Jie…[et al.]. The Effects of Xuefu Zhuyu and Shengmai on the Evolution of Syndromes and Inflammatory Markers in Patients with Unstable Angina Pectoris after Percutaneous Coronary Intervention : A Randomised Controlled Clinical Trial. Evidence-Based Complementary and Alternative Medicine No. 2013 (2013), pp.1-9.
https://search.emarefa.net/detail/BIM-506284
American Medical Association (AMA)
Wang, Jie& Yang, Xiaochen& Chu, Fuyong& Chen, Jianxin& He, Qingyong& Yao, Kuiwu…[et al.]. The Effects of Xuefu Zhuyu and Shengmai on the Evolution of Syndromes and Inflammatory Markers in Patients with Unstable Angina Pectoris after Percutaneous Coronary Intervention : A Randomised Controlled Clinical Trial. Evidence-Based Complementary and Alternative Medicine. 2013. Vol. 2013, no. 2013, pp.1-9.
https://search.emarefa.net/detail/BIM-506284
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-506284